Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionAbel Hall, LLC
Latest Disclosed Ownership21,100 shares
Latest Disclosed Value $ 1,279,715
Abel Hall, LLC reports 3.61% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 28, 2026 - Abel Hall, LLC filed a 13F-HR form disclosing ownership of 21,100 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,106,062 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 20,365 shares of Bristol-Myers Squibb Company. This represents a change in shares of 3.61% during the quarter. The current value of the position is $1,000,878 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 21,100 735 3.61 1,280 16.48 0.2726
2026-02-17 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 20,365 8,429 70.62 1,098 104.09 0.2565
2025-11-17 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 11,936 2,340 24.39 538 21.17 0.2174
2025-07-23 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 9,596 -6,727 -41.21 444 -55.38 0.2054
2025-05-06 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 16,323 -1,420 -8.00 996 -0.80 0.6008
2025-01-23 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,743 341 1.96 1,004 11.44 0.6395
2024-11-15 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,402 5,143 41.95 900 76.82 0.5894
2024-07-25 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 12,259 2,412 24.49 509 -4.68 0.3601
2024-05-08 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 9,847 5,571 130.29 534 143.84 0.3996
2024-02-28 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,276 4,276 219 0.1873
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.